İçeriğe geç

Travma ve Acil Tıp

Hemostaz Yönetimi ve Hemostazın İyi Duruma Getirilmesi

Antifibrinolitik İlaçlar

Alternatives to allogeneic platelet transfusion. (yeni pencere açar)

Desborough MJ, Smethurst PA, Estcourt LJ, Stanworth SJ.

Kaynak‎: Br J Haematol 2016;175(3):381-92.

İndeks‎: PubMed 27650431

DOI‎: 10.1111/bjh.14338

https://www.ncbi.nlm.nih.gov/pubmed/27650431 (yeni pencere açar)

Antifibrinolytic drugs for acute traumatic injury. (yeni pencere açar)

Ker K, Roberts I, Shakur H, Coats TJ.

Kaynak‎: Cochrane Database Syst Rev 2015;(5):CD004896.

İndeks‎: PubMed 25956410

DOI‎: 10.1002/14651858.CD004896.pub4

https://www.ncbi.nlm.nih.gov/pubmed/25956410 (yeni pencere açar)

Association of cryoprecipitate and tranexamic acid with improved survival following wartime injury: findings from the MATTERs II Study. (yeni pencere açar)

Morrison JJ, Ross JD, Dubose JJ, Jansen JO, Midwinter MJ, Rasmussen TE.

Kaynak‎: JAMA Surg 2013;148(3):218-25.

İndeks‎: PubMed 23670117

DOI‎: 10.1001/jamasurg.2013.764

https://www.ncbi.nlm.nih.gov/pubmed/23670117 (yeni pencere açar)

The importance of early treatment with tranexamic acid in bleeding trauma patients: an exploratory analysis of the CRASH-2 randomised controlled trial. (yeni pencere açar)

Roberts I, Shakur H, Afolabi A, Brohi K, Coats T, Dewan Y, Gando S, Guyatt G, Hunt BJ, Morales C, Perel P, Prieto-Merino D, Woolley T; CRASH-2 collaborators.

Kaynak‎: Lancet 2011;377(9771):1096-101, 1101.e1-2.

İndeks‎: PubMed 21439633

DOI‎: 10.1016/S0140-6736(11)60278-X

https://www.ncbi.nlm.nih.gov/pubmed/21439633 (yeni pencere açar)

Rekombinant Aktive Faktör VII (rFVIIa)

The treatment of bleeding is to stop the bleeding! Treatment of trauma-related hemorrhage. (yeni pencere açar)

Boffard KD, Choong PI, Kluger Y, Riou B, Rizoli SB, Rossaint R, Warren B; NovoSeven Trauma Study Group.

Kaynak‎: Transfusion 2009;49 Suppl 5:240S-7S.

İndeks‎: PubMed 19954486

DOI‎: 10.1111/j.1537-2995.2008.01987.x

https://www.ncbi.nlm.nih.gov/pubmed/19954486 (yeni pencere açar)

Pıhtılaşma Faktörü Konsantreleri

The exclusive use of coagulation factor concentrates enables reversal of coagulopathy and decreases transfusion rates in patients with major blunt trauma. (yeni pencere açar)

Innerhofer P, Westermann I, Tauber H, Breitkopf R, Fries D, Kastenberger T, El Attal R, Strasak A, Mittermayr M.

Kaynak‎: Injury 2013;44(2):209-16.

İndeks‎: PubMed 23000050

DOI‎: 10.1016/j.injury.2012.08.047

https://www.ncbi.nlm.nih.gov/pubmed/23000050 (yeni pencere açar)

Desmopressin

Desmopressin is a transfusion sparing option to reverse platelet dysfunction in patients with severe traumatic brain injury. (yeni pencere açar)

Furay EJ, Daley MJ, Satarasinghe P, Lara S, Aydelotte JD, Teixeira PG, Coopwood TB, Ali S, Brown CVR

Kaynak‎: J Trauma Acute Care Surg 2020;88(1):80-6.

İndeks‎: PubMed 31688782

DOI‎: 10.1097/TA.0000000000002521

https://www.ncbi.nlm.nih.gov/pubmed/31688782 (yeni pencere açar)

Cerrahiye ya da Pıhtılaşma Bozukluğuna Bağlı Kanamanın Tespitinde Viskoelastik Testler

Successful rotational thromboelastometry-guided treatment of traumatic haemorrhage, hyperfibrinolysis and coagulopathy. (yeni pencere açar)

Brenni M, Worn M, Brüesch M, Spahn DR, Ganter MT.

Kaynak‎: Acta Anaesthesiol Scand 2010;54(1):111-7.

İndeks‎: PubMed 19860752

DOI‎: 10.1111/j.1399-6576.2009.02132.x

https://www.ncbi.nlm.nih.gov/pubmed/19860752 (yeni pencere açar)